Bio-Techne Co. (NASDAQ:TECH) Receives $80.60 Consensus PT from Brokerages
Shares of Bio-Techne Co. (NASDAQ:TECH – Get Free Report) have been given an average recommendation of “Moderate Buy” by the ten analysts that are currently covering the stock, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 12 […]
More Stories
Standard Lithium (CVE:SLI) Trading Up 0.8% – Here’s Why
Shares of Standard Lithium Ltd. (CVE:SLI – Get Free Report) were up 0.8% on Thursday . The company traded as...
Nitori (OTC:NCLTY) Stock Price Down 0.6% – Time to Sell?
Nitori Holdings Co., Ltd. (OTC:NCLTY – Get Free Report)’s stock price fell 0.6% on Thursday . The company traded as...
Charlotte’s Web (TSE:CWEB) Trading Up 2.8% – Time to Buy?
Charlotte’s Web Holdings, Inc. (TSE:CWEB – Get Free Report)’s share price shot up 2.8% during trading on Thursday . The...
Urban Logistics REIT (OTC:PCILF) Stock Price Down 6.8% – Should You Sell?
Urban Logistics REIT plc (OTC:PCILF – Get Free Report) shares traded down 6.8% during mid-day trading on Thursday . The...
Titan Medical (NASDAQ:TMDIF) Stock Price Up 11.7% – What’s Next?
Titan Medical Inc. (NASDAQ:TMDIF – Get Free Report)’s share price traded up 11.7% during trading on Thursday . The stock...
iShares LifePath Target Date 2050 ETF (NYSEARCA:ITDF) Trading Down 0.1% – Here’s Why
iShares LifePath Target Date 2050 ETF (NYSEARCA:ITDF – Get Free Report)’s stock price were down 0.1% on Thursday . The...